Source: Annual Congress 2009 - Accuracy in lung function testing
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Zheng, M. Jiang, Y. Gao, J. Y. An, W. T. Liu, X. X. Yu (Guangzhou, China). Volume response are more significant and important than flow response to bronchodilator in patients with COPD. Eur Respir J 2009; 34: Suppl. 53, 2260

Member's Comments

No comment yet.

Related content which might interest you: Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Volumetric response to bronchodilators in flow non-responders with stable COPD Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Analysis of bronchodilator response in patients with controlled asthma Source: Eur Respir J 2004; 24: Suppl. 48, 223s Year: 2004 Influence of basal FEV1 on the response to bronchodilator agents in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001 Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006 The different results of the six minutes walking-test in COPD patients with or without significant improvement of inspiratory capacity after bronchodilator test Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004 IsovolumeFEF25-75%6 and FEV1 for identifying bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 156s Year: 2006 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Evaluation of bronchodilator responses in patients with advanced COPD Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Nasal high flow therapy: The effect on exercise performance in patients with COPD Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 A clinically significant bronchodilator response in children: how should it be measured? Source: Eur Respir J, 55 (5) 2000636; 10.1183/13993003.00636-2020 Year: 2020 Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005 Functional residual capacity is associated with increased response to albuterol and to methacholine in patients with intermittent mild asthma (Class I GINA) Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004 Emphysema phenotype predicts pattern of exercise response to bronchodilators in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 109s Year: 2005 Evaluation of vibration response imaging (VRI) in COPD and asthma patients before and after bronchodilators Source: Eur Respir J 2007; 30: Suppl. 51, 100s Year: 2007 How often FEV1 underestimates bronchodilator response? Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003